Selected research
Industry Research
Phenylpropanolamine Industry Research Report 2026
Market perspective
The global Phenylpropanolamine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Phenylpropanolamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Phenylpropanolamine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Phenylpropanolamine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Phenylpropanolamine include Abbott, GlaxoSmithKline (GSK), Tempo Scan Pacific, Schazoo, Sanofi-Aventis, Roemmers, Riemser Pharma, Medlink and Meda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Phenylpropanolamine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Phenylpropanolamine Market by Company
Abbott
GlaxoSmithKline (GSK)
Tempo Scan Pacific
Schazoo
Sanofi-Aventis
Roemmers
Riemser Pharma
Medlink
Meda
IBL Healthcare
Helicon
Gräub
Gracia Pharmindo
Eipico
Carinopharm
Asuncion
Armoxindo
Phenylpropanolamine Segment by Type
Capsule
Tablet
Syrup
Phenylpropanolamine Segment by Application
Human
Veterinary
Phenylpropanolamine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phenylpropanolamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Phenylpropanolamine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phenylpropanolamine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Phenylpropanolamine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Phenylpropanolamine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Phenylpropanolamine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Syrup
Applications
- Human
- Veterinary
Companies covered
- Abbott
- GlaxoSmithKline (GSK)
- Tempo Scan Pacific
- Schazoo
- Sanofi-Aventis
- Roemmers
- Riemser Pharma
- Medlink
- Meda
- IBL Healthcare
- Helicon
- Gräub
- Gracia Pharmindo
- Eipico
- Carinopharm
- Asuncion
- Armoxindo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Phenylpropanolamine Market Size (2021-2032)
- 2.2.2 Global Phenylpropanolamine Sales (2021-2032)
- 2.2.3 Global Phenylpropanolamine Market Average Price (2021-2032)
- 2.3 Phenylpropanolamine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.3.4 Syrup
- 2.4 Phenylpropanolamine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Human
- 2.4.3 Veterinary
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Phenylpropanolamine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Phenylpropanolamine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Phenylpropanolamine Revenue of Manufacturers (2021-2026)
- 3.4 Global Phenylpropanolamine Average Price by Manufacturers (2021-2026)
- 3.5 Global Phenylpropanolamine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Phenylpropanolamine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Phenylpropanolamine, Product Type & Application
- 3.8 Global Manufacturers of Phenylpropanolamine, Established Date
- 3.9 Global Phenylpropanolamine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Phenylpropanolamine Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 GlaxoSmithKline (GSK)
- 4.2.1 GlaxoSmithKline (GSK) Company Information
- 4.2.2 GlaxoSmithKline (GSK) Business Overview
- 4.2.3 GlaxoSmithKline (GSK) Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GlaxoSmithKline (GSK) Phenylpropanolamine Product Portfolio
- 4.2.5 GlaxoSmithKline (GSK) Recent Developments
- 4.3 Tempo Scan Pacific
- 4.3.1 Tempo Scan Pacific Company Information
- 4.3.2 Tempo Scan Pacific Business Overview
- 4.3.3 Tempo Scan Pacific Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Tempo Scan Pacific Phenylpropanolamine Product Portfolio
- 4.3.5 Tempo Scan Pacific Recent Developments
- 4.4 Schazoo
- 4.4.1 Schazoo Company Information
- 4.4.2 Schazoo Business Overview
- 4.4.3 Schazoo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Schazoo Phenylpropanolamine Product Portfolio
- 4.4.5 Schazoo Recent Developments
- 4.5 Sanofi-Aventis
- 4.5.1 Sanofi-Aventis Company Information
- 4.5.2 Sanofi-Aventis Business Overview
- 4.5.3 Sanofi-Aventis Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Sanofi-Aventis Phenylpropanolamine Product Portfolio
- 4.5.5 Sanofi-Aventis Recent Developments
- 4.6 Roemmers
- 4.6.1 Roemmers Company Information
- 4.6.2 Roemmers Business Overview
- 4.6.3 Roemmers Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Roemmers Phenylpropanolamine Product Portfolio
- 4.6.5 Roemmers Recent Developments
- 4.7 Riemser Pharma
- 4.7.1 Riemser Pharma Company Information
- 4.7.2 Riemser Pharma Business Overview
- 4.7.3 Riemser Pharma Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Riemser Pharma Phenylpropanolamine Product Portfolio
- 4.7.5 Riemser Pharma Recent Developments
- 4.8 Medlink
- 4.8.1 Medlink Company Information
- 4.8.2 Medlink Business Overview
- 4.8.3 Medlink Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Medlink Phenylpropanolamine Product Portfolio
- 4.8.5 Medlink Recent Developments
- 4.9 Meda
- 4.9.1 Meda Company Information
- 4.9.2 Meda Business Overview
- 4.9.3 Meda Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Meda Phenylpropanolamine Product Portfolio
- 4.9.5 Meda Recent Developments
- 4.10 IBL Healthcare
- 4.10.1 IBL Healthcare Company Information
- 4.10.2 IBL Healthcare Business Overview
- 4.10.3 IBL Healthcare Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 IBL Healthcare Phenylpropanolamine Product Portfolio
- 4.10.5 IBL Healthcare Recent Developments
- 4.11 Helicon
- 4.11.1 Helicon Company Information
- 4.11.2 Helicon Business Overview
- 4.11.3 Helicon Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Helicon Phenylpropanolamine Product Portfolio
- 4.11.5 Helicon Recent Developments
- 4.12 Gräub
- 4.12.1 Gräub Company Information
- 4.12.2 Gräub Business Overview
- 4.12.3 Gräub Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Gräub Phenylpropanolamine Product Portfolio
- 4.12.5 Gräub Recent Developments
- 4.13 Gracia Pharmindo
- 4.13.1 Gracia Pharmindo Company Information
- 4.13.2 Gracia Pharmindo Business Overview
- 4.13.3 Gracia Pharmindo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Gracia Pharmindo Phenylpropanolamine Product Portfolio
- 4.13.5 Gracia Pharmindo Recent Developments
- 4.14 Eipico
- 4.14.1 Eipico Company Information
- 4.14.2 Eipico Business Overview
- 4.14.3 Eipico Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Eipico Phenylpropanolamine Product Portfolio
- 4.14.5 Eipico Recent Developments
- 4.15 Carinopharm
- 4.15.1 Carinopharm Company Information
- 4.15.2 Carinopharm Business Overview
- 4.15.3 Carinopharm Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Carinopharm Phenylpropanolamine Product Portfolio
- 4.15.5 Carinopharm Recent Developments
- 4.16 Asuncion
- 4.16.1 Asuncion Company Information
- 4.16.2 Asuncion Business Overview
- 4.16.3 Asuncion Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Asuncion Phenylpropanolamine Product Portfolio
- 4.16.5 Asuncion Recent Developments
- 4.17 Armoxindo
- 4.17.1 Armoxindo Company Information
- 4.17.2 Armoxindo Business Overview
- 4.17.3 Armoxindo Phenylpropanolamine Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Armoxindo Phenylpropanolamine Product Portfolio
- 4.17.5 Armoxindo Recent Developments
5 Global Phenylpropanolamine Market Scenario by Region
- 5.1 Global Phenylpropanolamine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Phenylpropanolamine Sales by Region: 2021-2032
- 5.2.1 Global Phenylpropanolamine Sales by Region: 2021-2026
- 5.2.2 Global Phenylpropanolamine Sales by Region: 2027-2032
- 5.3 Global Phenylpropanolamine Revenue by Region: 2021-2032
- 5.3.1 Global Phenylpropanolamine Revenue by Region: 2021-2026
- 5.3.2 Global Phenylpropanolamine Revenue by Region: 2027-2032
- 5.4 North America Phenylpropanolamine Market Facts & Figures by Country
- 5.4.1 North America Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Phenylpropanolamine Sales by Country (2021-2032)
- 5.4.3 North America Phenylpropanolamine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Phenylpropanolamine Market Facts & Figures by Country
- 5.5.1 Europe Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Phenylpropanolamine Sales by Country (2021-2032)
- 5.5.3 Europe Phenylpropanolamine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Phenylpropanolamine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Phenylpropanolamine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Phenylpropanolamine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Phenylpropanolamine Market Facts & Figures by Country
- 5.7.1 South America Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Phenylpropanolamine Sales by Country (2021-2032)
- 5.7.3 South America Phenylpropanolamine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Phenylpropanolamine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Phenylpropanolamine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Phenylpropanolamine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Phenylpropanolamine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Phenylpropanolamine Sales by Type (2021-2032)
- 6.1.1 Global Phenylpropanolamine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Phenylpropanolamine Sales Market Share by Type (2021-2032)
- 6.2 Global Phenylpropanolamine Revenue by Type (2021-2032)
- 6.2.1 Global Phenylpropanolamine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Phenylpropanolamine Revenue Market Share by Type (2021-2032)
- 6.3 Global Phenylpropanolamine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Phenylpropanolamine Sales by Application (2021-2032)
- 7.1.1 Global Phenylpropanolamine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Phenylpropanolamine Sales Market Share by Application (2021-2032)
- 7.2 Global Phenylpropanolamine Revenue by Application (2021-2032)
- 7.2.1 Global Phenylpropanolamine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Phenylpropanolamine Revenue Market Share by Application (2021-2032)
- 7.3 Global Phenylpropanolamine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Phenylpropanolamine Value Chain Analysis
- 8.1.1 Phenylpropanolamine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Phenylpropanolamine Production Mode & Process
- 8.2 Phenylpropanolamine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Phenylpropanolamine Distributors
- 8.2.3 Phenylpropanolamine Customers
9 Global Phenylpropanolamine Analyzing Market Dynamics
- 9.1 Phenylpropanolamine Industry Trends
- 9.2 Phenylpropanolamine Industry Drivers
- 9.3 Phenylpropanolamine Industry Opportunities and Challenges
- 9.4 Phenylpropanolamine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst